Clinical trial
Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change
Abstract
The purpose of this study is to evaluate the change in patient-reported treatment satisfaction after 6 months of treatment with fingolimod 0.5mg/day vs. DMT standard of care, using the global satisfaction subscale of the Treatment Satisfaction Questionnaire for Medication (TSQM-9).
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Keywords
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.
Related research
ArticlePsilocybin
Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress.
ArticleAyahuasca
Analysis of 28 hair samples from users of the hallucinogenic beverage ayahuasca.
ArticleAyahuasca